Le Lézard
Classified in: Health
Subjects: LEG, AVO

Statement of Cathy Bennett, NJHA President and CEO, on the N.J. Legislature's Passage of Out-of-Network Legislation


PRINCETON, N.J., April 12, 2018 /PRNewswire-USNewswire/ -- "It's a good day when a diverse group of individuals and organizations can find common ground for the sake of healthcare consumers. The out-of-network bill approved today by the Senate and Assembly is eight years in the making, and in the end it addresses our two key priorities: protecting patients from surprise medical bills, and ensuring that hospitals and physicians are on a level playing field with insurance companies when it comes to negotiating fair payments for the care they deliver. We thank Speaker Coughlin, Senate President Sweeney and Senator Vitale for their ongoing dialogue with the hospital community on the detailed nuances and potential for unintended consequences in this issue. We urge Gov. Murphy to sign this bill into law as a major accomplishment in protecting patients."

SOURCE New Jersey Hospital Association (NJHA)


These press releases may also interest you

at 03:26
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...



News published on and distributed by: